Stephen Pound
Obstetrics & Gynecology · North Chesterfield, VANPI 1962636159
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 95.6% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 25 manufacturers, the largest accounting for just 12.1% — the pattern of someone who eats at a lot of different presentations.
Across 78 payments — averaging $17.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$164
- Biogen$144
- Pfizer$139
- Sumitomo Pharma America, Inc.$138
- Coopersurgical, Inc.$90
- Astellas Pharma US Inc$72
- plus $608 from 19 others
Across 209 payments — averaging $2613.86 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$259K
- AbbVie$161K
- GSK$89K
- Bayer$22K
- Sage Therapeutics, LLC$14K
What the payments were for
- Food & beverage$1,29696%
- Education$594%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 10 | $164 |
| Biogen | 8 | $144 |
| Pfizer | 10 | $139 |
| Sumitomo Pharma America, Inc. | 7 | $138 |
| Coopersurgical, Inc. | 3 | $90 |
| Astellas Pharma US Inc | 4 | $72 |
| Optumhealth Care Solutions, LLC | 2 | $67 |
| Bayer | 3 | $57 |
| Mayne Pharma Commercial LLC | 4 | $55 |
| Avion Pharmaceuticals | 4 | $48 |
| AMAG Pharmaceuticals, Inc. | 3 | $43 |
| Hologic Sales And Service, LLC | 2 | $43 |
| Lilly USA, LLC | 2 | $40 |
| Organon | 2 | $35 |
| Myovant Sciences Inc. | 2 | $33 |
| Medtronic | 2 | $33 |
| Therapeuticsmd, Inc. | 2 | $30 |
| Davol Inc. | 1 | $22 |
| Mylan Pharmaceuticals Inc. | 1 | $18 |
| Merck | 1 | $18 |
| Millicent US Inc | 1 | $16 |
| Daiichi Sankyo Inc. | 1 | $15 |
| Exeltis, USA Inc. | 1 | $13 |
| Novo Nordisk | 1 | $12 |
| Amgen | 1 | $11 |
How this compares
$1,356 in reported general payments places this provider in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| PremarinEstrogens, Conjugated | 16 | $8,004 |
| Estradiol | 64 | $3,583 |
| ValacyclovirValacyclovir Hcl | 21 | $790 |
| Estradiol (Once Weekly)Estradiol | 13 | $760 |
| Nystatin | 19 | $320 |
| Medroxyprogesterone Acetate | 11 | $320 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 13 | $290 |
| JunelNorethindrone Ac/Eth Estradiol | 11 | $280 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 23 | $160 |
| Alendronate Sodium | 27 | $78 |
| Fluconazole | 26 | $68 |
| Triamcinolone Acetonide | 13 | $42 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerPremarin | $139 | $8,00416 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 992 obstetrics & gynecology providers in Virginia.
Other obstetrics & gynecology in North Chesterfield
- Melissa FosterNorth Chesterfield$6K
- Thomas KimbleNorfolk$286K
- Jack AyoubLeesburg$279K
- Kurian ThottStafford$216K
- Nina SmithHarrisonburg$199K
- Joseph TroiseSalem$144K
- Bunan AlnaifChesapeake$139K
- James JonesRichmond$134K
- Melissa DelgadoVienna$95K
- Joann PinkertonCharlottesville$35K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.